Clinical trial
Evaluation of a TNF-Alpha Modulator for Clinical and Molecular Indicators of…
NCT00121563 · National Institute of Nursing Research (NINR), NIH · Completed
Key facts
| NCT number | NCT00121563 |
|---|---|
| Title | Evaluation of a TNF-Alpha Modulator for Clinical and Molecular Indicators of Analgesic Effect |
| Official title | Evaluation of TNF-Alpha Modulator for Clinical and Molecular Indicators of Analgesic Effect |
| Lead sponsor | National Institute of Nursing Research (NINR), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pain |
| Intervention type | Drug |
| Interventions | Thalidomide, Ibuprofen or Diazepam |
| Enrollment | 90 |
| Start date | Jul 1, 2005 |
| Completion | Feb 1, 2006 |
| First posted | Jul 21, 2005 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: